Site Reliability Engineer, Beacon Biosignals
$150-170k
+ equity
AI brain monitoring
Open for applications
AI brain monitoring
101-200 employees
Open for applications
$150-170k
+ equity
101-200 employees
Company mission
To improve human health by enabling rapid, targeted interventions through advanced brain analytics.
Jump to section
Company mission
To improve human health by enabling rapid, targeted interventions through advanced brain analytics.
40% employee growth in 12 months
Our take
The brain has long been considered one of the most mysterious fields of medicine - and psychiatric and neurological diseases therefore one of the least understood. Better access to real-time brain data, however, could change this and that’s exactly what Beacon Biosignals is hoping to deliver.
Beacon Biosignals has developed an AI-powered EEG platform designed to better measure and understand brain activity. Its technology includes a lightweight wearable headband that tracks brain signals during sleep and at home, feeding huge amounts of real-world data into machine-learning models. The aim is to help researchers analyze brain activity faster, identify new biomarkers, and improve the development of treatments for neurological and psychiatric disorders.
The company recently raised major funding and acquired home sleep testing specialist CleveMed as it expands its AI-powered brain health platform. Its FDA-cleared wearable headband is already being used in more than 40 clinical trails studying conditions like depression, Alzheimer's, Parkinson's, and sleep disorders. By collecting millions of hours of brain activity data, Beacon hopes to help researchers detect diseases earlier and better understand how the brain changes over time.
Kirsty
Company Specialist at Welcome to the Jungle
Funding (last 2 of 5 rounds)
Apr 2026
$11m
SERIES B
Nov 2025
$86m
SERIES B
Total funding: $127.5m
This company has top investors
Leadership
Jarrett Revels
(Co-Founder & CTO)Prior to co-founding Beacon Biosignals in 2019, Jarrett spent 4 years at Massachusetts Institute of Technology, joining as a Scientific Programmer before become a Performance Engineer then Research Software Developer.
Jacob Donoghue
(Co-Founder & CEO)Jacob completed a Neuroscience PhD at Massachusetts Institute of Technology, and received his MD from Harvard Medical School. Subsequently they carried out research for Cyberkinetics Neurotechnology Systems and Massachusetts General Hospital.
Brandon Westover
(Co-Founder)Received their MD from Washington University School of Medicine, then took up a Neurology residency at Harvard Medical School. Alongside their work at Beacon Biosignals, Brandon is also an HST Faculty member at MIT and a Neurologist/Medical AI Researcher at Massachusetts General Hospital.
Syd Cash
(Co-Founder)Syd is an Associate Professor at Harvard Medical School, who also leads the Center for Neurotechnology and Neurorecovery at MGH.
Jobs (9)
Software Engineering
Marketing
Operations & Strategy
Finance, Legal & Compliance
Other Engineering